First Trust Advisors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-123,568
| Closed | -$10.1M | – | 2600 |
|
|
2024
Q4 | $10.1M | Buy |
123,568
+5,704
| +5% | +$467K | 0.01% | 1053 |
|
|
2024
Q3 | $13.5M | Buy |
117,864
+38,938
| +49% | +$4.45M | 0.01% | 946 |
|
|
2024
Q2 | $5.96M | Buy |
78,926
+15,100
| +24% | +$1.14M | 0.01% | 1193 |
|
|
2024
Q1 | $4.36M | Sell |
63,826
-13,810
| -18% | -$943K | ﹤0.01% | 1370 |
|
|
2023
Q4 | $4.88M | Buy |
77,636
+44,923
| +137% | +$2.82M | 0.01% | 1277 |
|
|
2023
Q3 | $1.67M | Sell |
32,713
-2,691
| -8% | -$137K | ﹤0.01% | 1758 |
|
|
2023
Q2 | $1.77M | Sell |
35,404
-1,806
| -5% | -$90.2K | ﹤0.01% | 1777 |
|
|
2023
Q1 | $1.39M | Buy |
37,210
+16,749
| +82% | +$628K | ﹤0.01% | 1851 |
|
|
2022
Q4 | $981K | Buy |
+20,461
| New | +$981K | ﹤0.01% | 1967 |
|